SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.43 |
| Enterprise Value ($M) | 0.75 |
| Book Value ($M) | 2.72 |
| Book Value / Share | 1.70 |
| Price / Book | 0.89 |
| NCAV ($M) | 2.72 |
| NCAV / Share | 1.70 |
| Price / NCAV | 0.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.32 |
| Return on Assets (ROA) | -1.43 |
| Return on Equity (ROE) | -1.87 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.30 |
| Current Ratio | 4.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.55 |
| Assets | 3.55 |
| Liabilities | 0.83 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | MSD Partners, L.P. | 6.30 | -99.56 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,635 | 12,147 | 21.69 | |
| 11,248 | 53,246 | 21.12 | |
| 1,097 | 3,984 | 27.54 | |
| 5,075 | 8,712 | 58.25 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SXTC – China SXT Pharmaceuticals, Inc. | SXTP – 60 Degrees Pharmaceuticals, Inc. |
| SYBX – Synlogic, Inc. | TELO – Telomir Pharmaceuticals, Inc. |
| TENX – Tenax Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io